These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 5067256)
1. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. Mashieu P; Winand R J Clin Endocrinol Metab; 1972 Jun; 34(6):1090-2. PubMed ID: 5067256 [No Abstract] [Full Text] [Related]
2. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Mullin BR; Levinson RE; Friedman A; Henson DE; Winand RJ; Kohn LD Endocrinology; 1977 Feb; 100(2):351-66. PubMed ID: 401730 [TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. Munro RE; Lamki L; Row VV; Volpé R J Clin Endocrinol Metab; 1973 Aug; 37(2):286-92. PubMed ID: 4740520 [No Abstract] [Full Text] [Related]
4. Immunoglobulins (E,M,G) and complement in the connective tissues of the thyroid in Graves's disease. Werner SC; Wegelius O; Fierer JA; Hsu KC N Engl J Med; 1972 Aug; 287(9):421-5. PubMed ID: 4114629 [No Abstract] [Full Text] [Related]
5. Serum thyroglobulin, its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmos. Feldt-Rasmussen U; Kemp A; Bech K; Madsen SN; Date J Acta Endocrinol (Copenh); 1981 Feb; 96(2):192-8. PubMed ID: 6894054 [No Abstract] [Full Text] [Related]
6. Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue? Kiljanski J; Nebes V; Stachura I; Kennerdell JS; Wall JR Horm Metab Res; 1995 Dec; 27(12):528-32. PubMed ID: 8750780 [TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF). Lamki L; Row VV; Volpé R J Clin Endocrinol Metab; 1973 Feb; 36(2):358-64. PubMed ID: 4739173 [No Abstract] [Full Text] [Related]
8. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition. Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093 [TBL] [Abstract][Full Text] [Related]
9. Bullous pemphigoid and Graves' disease: an association between skin and thyroid autoimmunity. Fiorucci MC; Cozzani E; Casu M; Murialdo G; Parodi A; Rebora A Acta Derm Venereol; 2005; 85(6):560-1. PubMed ID: 16396820 [No Abstract] [Full Text] [Related]
10. Leukocyte migration test for the study of immune reactivity in cases of Graves disease associated with infiltrative ophthalmopathy. Kálmán K; Erdei I; Sándor P; Fazakas S; Leövey A Acta Med Acad Sci Hung; 1978; 35(1):29-34. PubMed ID: 581631 [TBL] [Abstract][Full Text] [Related]
11. Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease. Heufelder AE; Wenzel BE; Scriba PC J Clin Endocrinol Metab; 1996 Oct; 81(10):3733-9. PubMed ID: 8855831 [TBL] [Abstract][Full Text] [Related]
12. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. Salvi M; Zhang ZG; Haegert D; Woo M; Liberman A; Cadarso L; Wall JR J Clin Endocrinol Metab; 1990 Jan; 70(1):89-94. PubMed ID: 2294141 [TBL] [Abstract][Full Text] [Related]